Enovis logo
Enovis
ENOV | NYSE
Chart Builder DCF Calculator
$27.92
+$0.24 (+0.87%)
At close: Nov 16, 2026, 4:00 PM ET
$27.92
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:00 PM ET

Enovis Company Profile

Company profile explained

Company Profile

Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.

Key Executives

Name Position
Damien McDonald Chief Executive Officer & Director
Bradley J. Tandy Senior Vice President & Chief Legal Officer
Phillip Benjamin Berry Senior Vice President & Chief Financial Officer
John Kleckner Vice President, Controller & Chief Accounting Officer
Kyle William Rose Vice President of Investor Relations
Laura Singleton Senior Vice President & Chief Human Resources Officer
Louie Vogt Group President of Reconstructive
Oliver Engert Chief Administrative Officer
Patricia A. Lang Advisor
Terry Ross Group President Prevention & Recovery

Latest SEC Filings

Date Type Title
Oct 01, 2026 4 Filing
Sep 08, 2026 4 Filing
Sep 04, 2026 4 Filing
Sep 04, 2026 4 Filing
Sep 01, 2026 8-K Current Report
Aug 14, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Aug 06, 2026 10-Q Quarterly Report
Aug 06, 2026 8-K Current Report
Jul 28, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Jul 08, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
View All SEC Filings ➞
Enovis
Enovis logo
Country United States
IPO Date May 8, 2008
Industry Medical - Devices
Sector Healthcare
Employees 7,802
CEO Damien McDonald

Contact Details

2900 Lake Vista Drive Lewisville, Texas 75067 United States

Stock Details

Ticker Symbol ENOV
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001420800
CUSIP Number 194014502
ISIN Number US1940145022
SIC Code 3842

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.